Prostate cancer foci detected on multiparametric magnetic resonance imaging are histologically distinct from those not detected

Journal of Urology

Volumn 187, Issue 6, 2012, Pages 2032-2038

  Rosenkrantz, Andrew B ^a   Mendrinos, Savvas ^a   Babb, James S ^a   Taneja, Samir S ^b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

diffusion magnetic resonance imaging; magnetic resonance imaging; prostatic neoplasms

Indexed keywords

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIFFUSION WEIGHTED IMAGING; DYNAMIC CONTRAST ENHANCED IMAGING; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; LOGISTIC REGRESSION ANALYSIS; MALE; MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAMETERS; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; STROMA; TREATMENT PLANNING; TUMOR GROWTH; TUMOR VOLUME;

AGED; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 84861096940     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2012.01.074     Document Type: Article

References (25)

1. B. Turkbey, P.A. Pinto, H. Mani Prostate cancer: value of multiparametric MR imaging at 3 T for detection-histopathologic correlation Radiology 255 2010 89
2. J. Haffner, L. Lemaitre, P. Puech Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging-targeted and systematic biopsy for significant prostate cancer detection BJU Int 108 2011 E171
3. B. Turkbey, V.P. Shah, Y. Pang Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images? Radiology 258 2011 488
4. T. Franiel, C. Stephan, A. Erbersdobler Areas suspicious for prostate cancer: MR-guided biopsy in patients with at least 1 transrectal US-guided biopsy with a negative finding-multiparametric MR imaging for detection and biopsy planning Radiology 259 2011 162
5. O. Raz, M.A. Haider, S.R. Davidson Real-time magnetic resonance imaging-guided focal laser therapy in patients with low-risk prostate cancer Eur Urol 58 2010 173
6. D.L. Langer, T.H. van derKwast, A.J. Evans Intermixed normal tissue within prostate cancer: effect on MR imaging measurements of apparent diffusion coefficient and T2-sparse versus dense cancers Radiology 249 2008 900
7. A. Oto, A. Kayhan, Y. Jiang Prostate cancer: differentiation of central gland cancer from benign prostatic hyperplasia by using diffusion-weighted and dynamic contrast-enhanced MR imaging Radiology 257 2010 715
8. O. Akin, E. Sala, C.S. Moskowitz Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging Radiology 239 2006 784
9. T. Tamada, T. Sone, Y. Jo Prostate cancer: relationships between postbiopsy hemorrhage and tumor detectability at MR diagnosis Radiology 248 2008 531
10. S.W. Heijmink, J.J. Fütterer, T. Hambrock Prostate cancer: body-array versus endorectal coil MR imaging at 3 T-comparison of image quality, localization, and staging performance Radiology 244 2007 184
11. K. Kitajima, Y. Kaji, Y. Fukabori Prostate cancer detection with 3 T MRI: comparison of diffusion-weighted imaging and dynamic contrast-enhanced MRI in combination with T2-weighted imaging J Magn Reson Imaging 31 2010 625
12. N. Girouin, F. Mège-Lechevallier, A. Tonina Senes Prostate dynamic contrast-enhanced MRI with simple visual diagnostic criteria: is it reasonable? Eur Radiol 17 2007 1498
13. M.A. Haider, T.H. van derKwast, J. Tanguay Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer AJR Am J Roentgenol 189 2007 323
14. H. Miao, H. Fukatsu, T. Ishigaki Prostate cancer detection with 3-T MRI: comparison of diffusion-weighted and T2-weighted imaging Eur J Radiol 61 2007 297
15. E. Sivridis, A. Giatromanolaki, M.I. Koukourakis " Stromatogenesis" and tumor progression Int J Surg Pathol 12 2004 1
16. D.L. Langer, T.H. van derKwast, A.J. Evans Prostate tissue composition and MR measurements: investigating the relationships between ADC, T2, K(trans), v(e), and corresponding histologic features Radiology 255 2010 485
17. B. Zelhof, M. Pickles, G. Liney Correlation of diffusion-weighted magnetic resonance data with cellularity in prostate cancer BJU Int 103 2009 883
18. X.Z. Wang, B. Wang, Z.Q. Gao Diffusion-weighted imaging of prostate cancer: correlation between apparent diffusion coefficient values and tumor proliferation J Magn Reson Imaging 29 2009 1360
19. P. Gibbs, G.P. Liney, M.D. Pickles Correlation of ADC and T2 measurements with cell density in prostate cancer at 3.0 Tesla Invest Radiol 44 2009 572
20. J. Ren, Y. Huan, H. Wang Dynamic contrast-enhanced MRI of benign prostatic hyperplasia and prostatic carcinoma: correlation with angiogenesis Clin Radiol 63 2008 153
21. Y. Mazaheri, H. Hricak, S.W. Fine Prostate tumor volume measurement with combined T2-weighted imaging and diffusion-weighted MR: correlation with pathologic tumor volume Radiology 252 2009 449
22. V. Fradet, J. Kurhanewicz, J.E. Cowan Prostate cancer managed with active surveillance: role of anatomic MR imaging and MR spectroscopic imaging Radiology 256 2010 176
23. S.Y. Park, C.K. Kim, B.K. Park Prediction of biochemical recurrence following radical prostatectomy in men with prostate cancer by diffusion-weighted magnetic resonance imaging: initial results Eur Radiol 21 2011 1111
24. N.J. van As, N.M. de Souza, S.F. Riches A study of diffusion-weighted magnetic resonance imaging in men with untreated localised prostate cancer on active surveillance Eur Urol 56 2009 981
25. H. Hricak, S. White, D. Vigneron Carcinoma of the prostate gland: MR imaging with pelvic phased-array coils versus integrated endorectal-pelvic phased-array coils Radiology 193 1994 703